Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;22(6):297-300.
doi: 10.1007/s12471-014-0529-9.

Practical introduction of novel oral anticoagulants through an anticoagulation nurse. The Leeuwarden model

Affiliations

Practical introduction of novel oral anticoagulants through an anticoagulation nurse. The Leeuwarden model

R J Folkeringa et al. Neth Heart J. 2014 Jun.

Abstract

Introduction: This paper describes the implementation of novel oral anticoagulants (NOACs) through an anticoagulation nurse. Logistics and tasks of this new function are described and preliminary data are presented.

Methods: Indications for NOACs are explained by the treating cardiologists. Thereafter, the patient is referred to the anticoagulation nurse before starting a NOAC. After providing a patient with information and checking the creatinine clearance, co-medication and medical history, a prescription for NOAC is made.

Results: In 3 months, 51 patients were referred for NOAC therapy. Mean age was 68 years, CHA2DS2-VASc score was 2.9. Renal function was impaired in 28 %. Only 63 % of the patients had an uneventful start-up. NOAC therapy was withheld or prematurely stopped in 22 %. 30 % of patients needed a reduced NOAC dose. In 37 %, the anticoagulation nurse had extended patient contact, mainly because of (presumed) side effects.

Conclusion: Given the number of interactions that were made using a separate patient contact through the anticoagulation nurse, this seems to be an important improvement in the quality of care and deserves further expansion.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart of patients

References

    1. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Europace. 2010;12:1360–420. doi: 10.1093/europace/euq160. - DOI - PubMed
    1. Camm AJ, Lip GY, De Caterina R, et al. Focused update of the ESC guidelines for the management of atrial fibrillation. An update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385–413. doi: 10.1093/europace/eur416. - DOI - PubMed
    1. Werkgroep NOAC’s van de wetenschappelijke verenigingen en Orde van Medisch Specialisten. Leidraad begeleide introductie nieuwe orale antistollingsmiddelen.
    1. Landelijke stuurgroep keten antistollingsbehandeling. Landelijke standaard ketenzorg Antistolling voor de eerste- en tweedelijnszorg. www.knmp.nl. 2012.
    1. Heidbuchel H, Verhamme P, Alings M, et al. European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013;15:625–51. doi: 10.1093/europace/eut083. - DOI - PubMed

LinkOut - more resources